| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/15/2004 | US20040072151 Method of extracting virus genes and extraction apparatus |
| 04/15/2004 | US20040072150 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis A viral nucleic acid |
| 04/15/2004 | US20040072149 Method for identifying new anti-picornaviral compounds |
| 04/15/2004 | US20040072148 Simultaneous detection of HBV, HCV, and HIV in plasma samples using a multiplex capture assay |
| 04/15/2004 | US20040072147 Using oligonucleotide to screen for presence of drug resistant DNA viruses in fluids |
| 04/15/2004 | US20040072146 Using peptide modulator to prevent associations between adenine nucleotide translocator (ANT) and viral replication proteins (VPR); antiapoptosis |
| 04/15/2004 | US20040072145 Using oligonucleotides to detect viral nucleotide sequences in food; diagnosing food poisoning |
| 04/15/2004 | US20040071738 Hypo-allergenic pollen protein treated with thioredoxin, nicotinamide adenine dinucleotide phosphate- thioredoxin reductase (NTR) and reduced nicotinamide adenine dinucleotide phosphate (NADPH) |
| 04/15/2004 | US20040071711 Imaging, diagnosis and treatment of disease |
| 04/15/2004 | US20040071709 Corona-virus-like particles comprising functionally deleted genomes |
| 04/15/2004 | US20040071699 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 04/15/2004 | US20040071689 Administering library then collecting and analyzing sample of biological target material |
| 04/15/2004 | US20040071686 Treatment of alpha-galactosidase A deficiency |
| 04/15/2004 | US20040071683 Methods for treating pervasive development disorders |
| 04/15/2004 | US20040071603 Forming high density arrays with smaller feature size and spacings; efficient reagent usage |
| 04/15/2004 | US20040071327 Histological reconstruction and automated image analysis |
| 04/15/2004 | US20040069707 Method of isolating a charged compound |
| 04/15/2004 | US20040069635 Electrophoresis using the charged nature of the biomolecules to localize them to a microspot containing a dialysis membrane; high throughput method for analysis and quantitation |
| 04/15/2004 | US20040069628 For quantifying a substrate contained in a sample, such as blood; oxidoreductase is provided on the cover member so as not to overlap with the position of the electron mediator. |
| 04/15/2004 | DE19710287B4 Mikrobiologischer Biosensor, Verfahren zu seiner Herstellung und seine Verwendung Microbiological biosensor, procedures for its preparation and its use |
| 04/15/2004 | DE10246339A1 Predicting risk, and diagnosis, of chemical-induced disease, e.g. chronic fatigue syndrome, comprises determining allelic status of genes involved in the detoxification process |
| 04/15/2004 | DE10244456A1 Verfahren zum Nachweis und Differenzierung von Bakterien A method for the detection and differentiation of bacteria |
| 04/15/2004 | DE10132147B4 Verfahren zur schnellen quantitativen Bestimmung von Eu-Bakterien Method for the rapid quantitative determination of Eu bacteria |
| 04/15/2004 | CA2501481A1 Detecting the risk of cardiovascular diseases by detecting mutations in genes, including genes encoding a2b-adrenoceptor and apolipoprotein b |
| 04/15/2004 | CA2501295A1 Methods of generating and screening for proteases with altered specificity |
| 04/15/2004 | CA2501063A1 Substrates for o6-alkylguanine-dna alkyltransferase |
| 04/15/2004 | CA2501061A1 Protein labelling with o6-alkylguanine-dna alkyltransferase |
| 04/15/2004 | CA2501030A1 Method and kit for quantitative and qualitative determination of human papillomavirus |
| 04/15/2004 | CA2500982A1 Method for diagnosing testicular seminomas |
| 04/15/2004 | CA2500904A1 Composition containing eosinophil cationic protein |
| 04/15/2004 | CA2500861A1 Method for diagnosing prostate cancer |
| 04/15/2004 | CA2500859A1 Genes and polypeptides relating to prostate cancers |
| 04/15/2004 | CA2500670A1 Ratios of collagen peptides, their uses and products |
| 04/15/2004 | CA2500538A1 Method for treating or preventing metastasis of colorectal cancers |
| 04/15/2004 | CA2500531A1 Method for treating or preventing metastasis of colorectal cancers |
| 04/15/2004 | CA2500482A1 Method for diagnosing pancreatic cancer |
| 04/15/2004 | CA2500472A1 Genes and polypeptides relating to human pancreatic cancers |
| 04/15/2004 | CA2500470A1 Method for diagnosing chronic myeloid leukemia |
| 04/15/2004 | CA2500464A1 Method for detecting and counting micro-organisms in a sample |
| 04/15/2004 | CA2500405A1 Genes and polypeptides relating to human myeloid leukemia |
| 04/15/2004 | CA2500151A1 Ttk protein kinase gene for diagnosing and treating non-small cell lung cancers |
| 04/15/2004 | CA2499734A1 Genetic diagnosis of depression |
| 04/15/2004 | CA2499483A1 Novel chemokine-like polypeptides |
| 04/15/2004 | CA2498631A1 Use of a33 antigens and jam-it |
| 04/15/2004 | CA2484335A1 Use of molecules which interact with the haptoglobin receptor ligand binding |
| 04/14/2004 | EP1408334A1 Procalcitonin 3-116 |
| 04/14/2004 | EP1408333A2 Diagnosis and treatment of Alzheimer's disease |
| 04/14/2004 | EP1408122A2 Methods and compositions for efficient nucleic acid sequencing |
| 04/14/2004 | EP1408121A2 Genetic test to determine non-responsiveness to statin drug treatment |
| 04/14/2004 | EP1408120A2 Detection of vancomycin-resistant Enterococcus spp. |
| 04/14/2004 | EP1408119A1 Method of screening abc protein promoter/inhibitor |
| 04/14/2004 | EP1408118A1 Enzymatic method of producing 4-0-b-d galactopyranosyl-d-xylose, 4-0-b-d-galactopyranosyl-d-xylose obtained using said method, compositions containing same and the use thereof in evaluating intestinal lactase |
| 04/14/2004 | EP1408110A2 Oligonucleotide mediated specific cytokine induction and in vivo protection from infection |
| 04/14/2004 | EP1408108A2 Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same |
| 04/14/2004 | EP1408090A1 Dibenzorhodamine dyes useful as fluorescent labelling agents |
| 04/14/2004 | EP1408049A2 A novel inositol 1,4,5-trisphosphate (IP3) receptor-binding protein and an IP3 indicator |
| 04/14/2004 | EP1407816A1 Method for arranging a polymer molecule |
| 04/14/2004 | EP1407274A2 Method for identifying micro-organisms using mass spectrometry |
| 04/14/2004 | EP1407273A2 Methods of assessing wolframin protein activity |
| 04/14/2004 | EP1407270A2 Methods for the identification of inhibitors of 3-oxo-5-alpha-steroid 4-dehydrogenase expression or activity in plants |
| 04/14/2004 | EP1407269A2 A method for diagnosing a person having multiple sclerosis |
| 04/14/2004 | EP1407264A1 Caged compound cleaving process |
| 04/14/2004 | EP1407263A2 Method for the extra-corporeal qualitative and/or quantitative recording of neuro-toxic substances in the blood plasma of an individual |
| 04/14/2004 | EP1407257A1 Microfabricated separation device employing a virtual wall for interfacing fluids |
| 04/14/2004 | EP1407053A2 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith |
| 04/14/2004 | EP1407052A2 Method for monitoring and modulating protein folding |
| 04/14/2004 | EP1407051A2 Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection |
| 04/14/2004 | EP1407050A2 Method for rapid amplification of dna |
| 04/14/2004 | EP1407048A1 Detection of single nucleotide polymorphisms |
| 04/14/2004 | EP1407047A1 METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN BASED ON GLUTATHIONE-S-TRANSFERASE Pi EXPRESSION |
| 04/14/2004 | EP1407046A1 Method of dna sequencing using cleavable tags |
| 04/14/2004 | EP1407045A2 Retinoid pathway assays, and compositions therefrom |
| 04/14/2004 | EP1407044A2 Rna interference mediating small rna molecules |
| 04/14/2004 | EP1407043A2 Gamma-secretase in vitro screening assay |
| 04/14/2004 | EP1407042A2 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 04/14/2004 | EP1407041A1 Method for obtaining a titrated preparation of algae and resulting titrated preparations |
| 04/14/2004 | EP1407040A2 Device and method for detecting photosynthesis inhibition |
| 04/14/2004 | EP1407033A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 04/14/2004 | EP1407019A2 Intestinal proteins |
| 04/14/2004 | EP1407016A2 Compositions and methods relating to breast specific genes and proteins |
| 04/14/2004 | EP1407015A2 Compositions and methods relating to breast specific genes and proteins |
| 04/14/2004 | EP1407014A2 Screening method for attenuating or virulence defective microbial cells |
| 04/14/2004 | EP1407013A1 Mutations in ion channels |
| 04/14/2004 | EP1407012A1 Methods of creating genetic diversity |
| 04/14/2004 | EP1407010A1 Regulation of human aminopeptidase n |
| 04/14/2004 | EP1407009A2 Hydrolase enzymes and their use in kinetic resolution |
| 04/14/2004 | EP1406998A2 Liver engrafting cells, assays, and uses thereof |
| 04/14/2004 | EP1406997A2 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor |
| 04/14/2004 | EP1406928A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 04/14/2004 | EP1406925A2 Survivin interacting protein tpr1 |
| 04/14/2004 | EP1406923A2 Histidine phosphatase interacting protein with 180kd |
| 04/14/2004 | EP1406920A1 Novel chromogenic substances and use thereof for the determination of carboxypeptidase activities |
| 04/14/2004 | EP1406916A2 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 04/14/2004 | EP1406906A1 Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
| 04/14/2004 | EP1406765A1 Droplet dispensing system |
| 04/14/2004 | EP1406720A1 Buffers for electrophoresis and use thereof |
| 04/14/2004 | EP1406664A2 Targeting chemical compounds to cells |
| 04/14/2004 | EP1406653A2 T cell regulatory genes and methods of use thereof |
| 04/14/2004 | EP1406652A2 Novel drug targets for arthritis |
| 04/14/2004 | EP1406621A2 Compositions and methods for inhibiting platelet activation and thrombosis |